Reiterated terminal sequences of Epstein-Barr virus (EBV) DNA are numerically heterogeneous among infectious virions, providing a viral measure of clonality in infected cells. After in vitro infection, carcinoma cells bearing EBV episomes with fewer terminal repeats (TRs) proliferated faster. In single-cell clones, TR number varied inversely to the quantity of latent membrane protein 2A (LMP2A) transcripts whose unspliced precursors cross joined TRs. Thus, EBV clonality may reflect selection for a TR number that optimizes LMP2A-enhanced tumor progression, with infection occurring after epithelial cell transformation.
Epstein-Barr virus (EBV) has been linked to numerous human tumors of diverse tissue origin: nasopharyngeal carcinoma, Burkitt's lymphoma, Hodgkin's lymphoma, gastric carcinoma, T-cell lymphomas, leiomyosarcoma, and breast cancer (24) . Although the association of EBV with cancers such as gastric carcinoma (ϳ15%), Hodgkin's lymphoma (40 to 60%), and sporadic Burkitt's lymphoma (ϳ30%) is less than complete, assignment of a causal role to EBV has been based in part on the perception that these diseases are clonal expansions of a single EBV-infected cell (2, 23) . Upon entry, linear EBV DNA circularizes by homologous recombination of its terminal repeats (TRs), producing fused termini of unique length for each circularization event (13) . Unlike the length heterogeneity found with a mixed-cell population at primary infection, fused TRs with an identical number of repeat units denote expansions of a single infected progenitor (Fig. 1A) . Detection of a single form of EBV in all tumor cells indicates that cellular proliferation occurred after EBV infection and argues for an etiologic role for virus in these tumors (20, 23) .
What is less evident from clonality data is whether EBV infection facilitates tumor initiation or subsequent malignant progression (22, 32) , an issue central to understanding viral pathogenesis. The fact that EBV is present prior to clonal expansion is intuitive evidence for a viral role in an early, initiating event. Indeed, it has been argued that if EBV were to infect preexisting neoplastic lesions, one would expect either a polyclonal pattern of TRs or the lack of EBV altogether in some tumor cells. Here, we present evidence from carcinoma cell lines infected in vitro that suggests that this need not be the case. Instead, EBV clonality postinfection may be a consequence of a selective growth advantage conferred by viral episomes with a minimal number of TRs.
Our experiments stemmed from the unexpected observation, also made by others, that in vitro infection of established epithelial cell lines frequently gives rise to a clonal pattern by EBV TR analysis (3, 15) . To determine the basis for this outcome, we infected established human carcinoma cell lines with a recombinant EBV whose expression of the neomycinresistance gene would force retention of all viral genomes in cells maintained under antibiotic pressure. EBV Neo r (a gift of L. Hutt-Fletcher, University of Missouri-Kansas City) was generated by insertion of a neomycin resistance cassette in the BDLF3 open reading frame of the EBV strain Akata (1). Viral stocks were produced by treatment of host cells with antihuman immunoglobulin G (1, 30 ), which were determined not to express the B-lymphocyte EBV receptor CD21 (data not shown), were incubated for 24 h with 0.5 ml of Akata culture supernatant containing EBV Neo r and then resuspended in Dulbecco's modified Eagle medium containing 350 g of G418/ml. When G418-resistant cells became confluent, they were examined by Southern blot analysis for the configuration of EBV termini by using the BamHI NJ het fragment of EBV DNA as the probe as described previously (23) (Fig. 1A) . Five of the eight cell lines were successfully infected and contained EBV episomes, corroborating similar evidence from other laboratories indicating an as-yet-unknown epithelial cell receptor (11) . When forced under antibiotic pressure to retain virus, infected cell lines demonstrated a polyclonal pattern at early passage (Fig. 1B) . However, infections that were initially polyclonal rapidly evolved to predominance by single episomes over time in culture (Fig. 1C) .
Because episomes with minimal TRs seemed to prevail in bulk culture (Fig. 1C) , we examined whether the length of joined termini correlated with the host cell population doubling time. First, single-cell clones of the infected CCL-20.2 epithelial cell line were derived by cell sorting (FACSVantage SE; Becton Dickinson, San Jose, Calif.) and the relative size of joined EBV DNA ends was determined by analysis of EBV termini. Unlike the infected parental cell line that was polyclonal at early passage by virtue of the distinct TR size attributable to each cell, resultant cell clones contained uniform episomal populations with TRs that ranged in size from approximately 4 to 20 repeat units ( Fig. 2A) . When seeded at 8 ϫ (14, 28) . Arrows labeled 5Ј and 3Ј represent the forward and reverse PCR primers, respectively, used to quantify LMP2A gene expression. UL, unique long DNA sequences; US, unique short; IR, internal repeats. (B) Fused TR in three Burkitt's lymphoma cell lines shown by Southern blot analysis, ranging from ϳ14 reiterations in Glor to ϳ2 in Tiazaru (estimates take into account 7.5 kb of unique DNA flanking the 500-bp repeats in the 10 3 cells/ml in the presence of G418, two separate clones with the fewest repeats (clones 23 and 25) had an average population doubling time of 31 h, while clones with the most repeats (clones 30 and 33) doubled in 46 h (Fig. 2B) . By comparison, individual CCL-20.2 clones not infected with virus did not differ in doubling times, ruling out clonal variation as an explanation for differences in growth rates (data not shown). Moreover, when equivalent cell numbers from infected clones 23, 25, 30, and 33 were combined in mixed culture, clones containing episomes with the fewest TRs emerged as the predominant cell population within as few as eight passages (Fig.  2C) .
Malignancies associated with EBV are often grouped according to which of nine EBV latency proteins are expressed in tumor tissue (24) . The restricted expression patterns in nasopharyngeal carcinoma, gastric carcinoma, and Hodgkin's lymphoma typically include one or both latent membrane proteins, LMP1 and LMP2A, each of which affects epithelial cell growth and differentiation pathways (4, 7, 29, 31) . With either protein, TR number has at least the potential to affect levels of expression. For example, LMP2A is encoded by a spliced gene with exons located at either end of the viral genome (Fig. 3A) .
Consequently, its open reading frame is created only after circularization of the linear DNA molecule following viral entry into cells (14, 28) . Transcription proceeds across fused TRs, whose 500-bp units may vary by as many as 15 to 20 reiterations in infected lymphocyte clones from a single individual (2) . In the case of LMP1, there is a transcriptional enhancer located in the viral origin of plasmid replication, oriP, that acts across the TRs to increase expression of LMP1 (9) . Moreover, the activity of an LMP1 TATA-less promoter located in the first TR and functional in epithelial cells might be influenced by TR number (27) .
Because levels of LMP2A have been shown to differ significantly between B-cell lines (21), we first quantified by reverse transcriptase (RT) PCR the LMP2A mRNA levels in three endemic Burkitt's lymphoma lines (Glor, Salina, and Tiazaru; gift of A. B. Rickinson, University of Birmingham, Birmingham, United Kingdom) containing episomes with diminishing TR number as shown by analysis of EBV termini (Fig. 3B) . In brief, for cDNA synthesis, 5 g of total RNA was reverse transcribed with Moloney murine leukemia virus RT (Gibco BRL, Rockville, Md.) by using random hexamer primers. LMP2A-specific primers were selected (Primer Express 1.5; PE Applied Biosystems, Foster City, Calif.) such that the forward primer spanned the boundary between the first and second exons (5Ј-AGCGGGCAGAGGAAG-3Ј, base coordinate 166444; National Center for Biotechnology Information GenBank accession no. AJ507799) and the reverse primer was located in exon 2 (5Ј-AAGAGGTAGGGCGCAACAATT-3Ј, base coordinate 102). The TaqMan fluorogenic system (PE Applied Biosystems), in which real-time amplification was measured by cleavage of a fluorescent dye-labeled LMP2A-specific probe (5Ј FAM-TCCAGTATGCCTGCCTG-TA MRA 3Ј, base coordinate 64) by the 5Ј-to-3Ј exonuclease activity of Taq DNA polymerase, was used as described elsewhere (10) . Reactions were performed in a 50-l volume with 50 to 500 ng of cDNA by using TaqMan Universal master mix (PE Applied Biosystems) and universal thermocycler conditions according to the manufacturer's instructions (ABI Prism 7700 sequence detection system; PE Applied Biosystems). Template-negative and RT-negative reactions served as controls. All samples were run in duplicate, together with reactions to quantify expression of an internal control gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene (PE Applied Biosystems), to normalize for any differences in the amount of total RNA added.
By quantitative RT-PCR, LMP2A mRNA levels were found to vary inversely to TR number in Burkitt's lymphoma lines derived from three individuals (Fig. 3C ). The differences in LMP2A mRNA (n-fold), normalized to GAPDH, were 1, 39, and 247 for the Glor, Salina, and Tiazaru cell lines, respectively. No product was obtained in the RT-negative or template-negative controls. To ensure that levels of transcripts reflected intervening TR length, not disparate EBV genome equivalents within cell lines, viral copy number was determined by real-time PCR of the BamHI K region of EBV DNA as previously described (10) . Transcript levels normalized to EBV DNA copy number did not substantially alter these results (data not shown).
Unlike the monoclonal Burkitt's lymphoma lines originating from different hosts, single-cell clones derived from the experimentally infected epithelial cell line CCL20.2 ( Fig. 2A) afforded a common cell background in which to measure the relation of length of joined termini to LMP2A transcript level. In epithelial cell clones, a similar inverse relationship was observed wherein increased size of joined termini corresponded with lower levels of LMP2A mRNA (Fig. 3D ). Higher levels of LMP2A mRNA correlated precisely with accelerated rates of epithelial cell proliferation (Fig. 2B) . In addition, immunoprecipitation of LMP2A protein from the two epithelial cell clones that exhibited an eightfold difference in LMP2A mRNA levels revealed an approximately twofold difference in LMP2A protein by densitometric analysis (Fig. 4A) . Repeat immunopreBamHI restriction fragment). (C) Real-time RT-PCR amplification profile of LMP2A mRNA in the cell lines in panel B (labeled 1 to 3), with RT-negative and EBV-negative control reactions falling below threshold levels. Data analysis was performed using ABI Prism 7700 sequence detection system software (PE Applied Biosystems), with cycle threshold (C T ) values being determined by automated threshold analysis. The fluorescence intensity (⌬Rn) collected in real time for each sample was plotted against the number of PCR cycles. The black horizontal line represents the threshold setting, set at 10 standard deviations above the baseline. The C T value is defined as the fractional cycle number in which the fluorescence generated within a reaction has crossed the threshold. This value indicates that a sufficient number of amplicons have accumulated to be at a statistically significant point above the baseline. C T values inversely correlate with target gene expression. The comparative C T method (⌬⌬C T ), with the GAPDH gene expression as the cellular RNA control, was used to assess relative differences in LMP2A transcript levels between single-cell clones according to the manufacturer's protocol. (D) Relative differences (n-fold) in LMP2A mRNA levels in CCL-20.2 epithelial cell clones. Shown are average values from two separate experiments in which samples were run in duplicate as in panel C and transcript levels were normalized to EBV copy number as determined by real-time PCR for the BamHI K region of EBV DNA (10) . Clones 23 and 25 contain EBV episomes with the least TRs; clones 30 and 33 have the most TRs. cipitation of the spent substrates was negative, indicating that all LMP2A protein was blotted in the original analysis.
In contrast to LMP2A mRNA, LMP1 mRNA was not detected in any of the epithelial cell clones by RT-PCR with primers that would amplify transcripts initiated at both LMP1 promoters (5Ј-AGACAAGTAAGCACCCGAAGAT-3Ј, base coordinate 168505; 5Ј-GCCCTTTGTATACTCCTACTGAT G-3Ј, base coordinate 168773; and probe 5Ј FAM-CCCTCCT GCTCATCGCTCCTGGA-TAMRA 3Ј) (data not shown). Consistent with the absence of transcripts, LMP1 protein was also not detected by immunoblotting (Fig. 4B) .
Although the inverse correlation between LMP2A transcription and TR unit length held for both lymphoid and epithelial cell types, the actual biologic impact in epithelial cells may be quite different. The ability of LMP2A to induce epithelial cell transformation contrasts with its effect in B cells, where it is thought to contribute to maintenance of viral latency but not to be required for cell transformation (16, 18, 29) . The mechanism by which TR unit length influences LMP2A transcript level is yet to be defined. One possibility is that CpG methylation, evident within the GC-rich TRs, inhibits RNA transcript elongation, as has been shown previously for 3Ј structural regions of genes including the herpes simplex thymidine kinase gene (5, 12, 25) .
Our results, demonstrating clonal emergence of epithelial cells bearing episomes with minimal TRs, do not infer that all EBV-associated carcinomas contain episomes of a uniformly sparse TR number. Indeed, the sizes of fused EBV termini vary considerably between individual tumors (20, 23) . Instead, these data support the notion that nascent tumors infected early after clonal expansion, though initially polyclonal with respect to EBV episomal TR number, rapidly select for malignant subclones bearing episomes with comparatively few TRs relative to the range within that tumor.
Infection of preexisting neoplasia by endogenous EBV runs contrary to the current view of EBV tumorigenesis, yet it is consistent with the long-standing observation that onset of EBV malignancies in healthy virus carriers may be preceded for months to years by elevated antibody titers to EBV lytic antigens, indicating viral reactivation (6, 19, 33) . Implicit in such a reversed order of events is that EBV participates in tumor progression, not initiation, a notion corroborated by the contribution of LMP2A to epithelial cell growth (29) . Indeed, our results linking optimal LMP2A expression to minimal in- tervening TR sequences and ensuing epithelial cell clonal emergence are consistent with experimental data from a mouse tumorigenicity model showing selection for cells with high levels of LMP2A in the newly derived tumors (29) . Cell transformation with the extant possibility of subsequent EBV infection provides a logical explanation for the less-than-complete association of virus with malignancies of similar histogenetic phenotype and is a sequence of events entirely compatible with the detection of clonal EBV in diverse human cancers.
